Hall Ashley
SEC CIK 1801842 · EDGAR
BoughtSold
Most active insiders at GPCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Berrios John Joseph | Chief Commercial Off | — | — |
| 2 | Coll Crespo Blas | Chief MEDICAL Off | — | — |
| 3 | Ma Yingli | CTO | — | — |
| 4 | Lin Xichen | CSO | — | — |
| 5 | Yoon Jun | CFO | — | — |
| 6 | Hall Ashley | Chief Development Off | — | — |
| 7 | Lang Matthew | COO, GC | — | — |
| 8 | Stevens Raymond C | CEO, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-23 | 2026-03-19 | GPCR | Structure Therapeutics Inc. | Hall Ashley | Chief Development Off | A - Grant | $0.00 | +47.7K | 155.2K | +44% | $0 |
| D | 2026-03-05 | 2026-03-03 | GPCR | Structure Therapeutics Inc. | Hall Ashley | Chief Development Off | F - Tax | $20.99 | -4,836 | 107.5K | -4% | -$101.5K |
| 2025-09-22 | 2025-09-18 | GPCR | Structure Therapeutics Inc. | Hall Ashley | Chief Development Off | F - Tax | $7.74 | -6,021 | 112.3K | -5% | -$46.6K | |
| D | 2025-03-18 | 2025-03-15 | GPCR | Structure Therapeutics Inc. | Hall Ashley | Chief Development Off | A - Grant | $0.00 | +51.0K | 118.3K | +76% | $0 |
| D | 2024-09-20 | 2024-09-18 | GPCR | Structure Therapeutics Inc. | Hall Ashley | Chief Development Off | A - Grant | $0.00 | +67.3K | 67.3K | New | $0 |
| D | 2023-08-29 | 2023-08-28 | OKUR | OnKure Therapeutics, Inc. | Hall Ashley | Chief Development Off | S - Sale+OE | $6.28 | -15.6K | 39.6K | -28% | -$98.1K |
| D | 2023-08-29 | 2023-08-28 | OKUR | OnKure Therapeutics, Inc. | Hall Ashley | Chief Development Off | M - OptEx | $1.80 | +15.6K | 55.2K | +39% | +$28.1K |
| D | 2021-11-15 | 2021-11-12 | OKUR | OnKure Therapeutics, Inc. | Hall Ashley | Chief Development Off | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations